Dr. Peter Attia

And why do those patients with marrow that's still producing CD20 positive cells not go on in a constant state of lymphoma requiring? In other words, why is it that you can treat this and create a durable remission?

And why do those patients with marrow that's still producing CD20 positive cells not go on in a constant state of lymphoma requiring? In other words, why is it that you can treat this and create a durable remission?

So it's just getting rid of enough of the diseased B cells until you get the load down low enough that the immune system can wipe out the clone.

So it's just getting rid of enough of the diseased B cells until you get the load down low enough that the immune system can wipe out the clone.

What was the price of these drugs at the time they came out? Were these the first chemotherapeutic agents, or you kind of want to distinguish them from traditional chemo, but were these the first oncology drugs that came with big price tags?

What was the price of these drugs at the time they came out? Were these the first chemotherapeutic agents, or you kind of want to distinguish them from traditional chemo, but were these the first oncology drugs that came with big price tags?

And about this time, we get the whole anti-VEGF story, right? Yeah.

And about this time, we get the whole anti-VEGF story, right? Yeah.

That was... So Judah Folkman over at Boston Children's.

That was... So Judah Folkman over at Boston Children's.

Yeah. I never had the chance to meet him.

Yeah. I never had the chance to meet him.

I've never met Judah. He wrote a fantastic book that I read in medical school, poured over the book. I'm blanking on the name of it. Do you remember the book? It was his story.

I've never met Judah. He wrote a fantastic book that I read in medical school, poured over the book. I'm blanking on the name of it. Do you remember the book? It was his story.

Again, a beautiful story.

Again, a beautiful story.

You know, the saying that I love is it's the description of science as a beautiful, compelling hypothesis slayed by an ugly fact.

You know, the saying that I love is it's the description of science as a beautiful, compelling hypothesis slayed by an ugly fact.

Mostly human.

Mostly human.